| 0000-00-00 |
|
|
|
External link to document |
| 2023-08-10 |
1 |
Complaint |
prior to the
expiration of U.S. Patent Nos. 7,214,695 (“the ’695 patent”) (attached as Exhibit A), 7,214,696… 1. This is an action for patent infringement under the patent laws of the United States,
Title…declaratory judgment of patent infringement under 28 U.S.C.
§§ 2201 and 2202 and the patent laws of the United…7,214,696
(“the ’696 patent”) (attached as Exhibit B), and 9,770,441 (“the ’441 patent”) (attached as Exhibit…Exhibit
C). These three patents are referred to collectively as “the patents-in-suit.”
Case 1:23-cv-00879 |
External link to document |
| 2024-10-16 |
106 |
Letter |
is a Hatch-Waxman patent infringement action involving U.S. Patent Nos. 7,214,695,
7,214,696, and 9,…9,770,441 (collectively, “Asserted Patents”), which are listed in the U.S. Food and
Drug Administration…alleging
infringement of one or more of the Asserted Patents in connection with Dexcel’s filing of
Abbreviated…the expiration
of one or more of the Asserted Patents. Plaintiffs filed a second Complaint against Aurobindo… United
States prior to the expiration of U.S. Patent No. 7,214,696. The cases were consolidated for |
External link to document |
| 2024-10-29 |
109 |
Notice of Service |
Initial Invalidity Contentions for U.S. Patent Nos. 7,214,695 and 7,214,696 filed by Aurobindo Pharma … INVALIDITY CONTENTIONS FOR U.S. PATENT NOS. 7,214,695 AND 7,214,696
were served upon the attorneys… 10 August 2023
1:23-cv-00879
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2023-08-10 |
3 |
ANDA Form |
Expiration of Patent: U.S. Patent No. 7,214,695 expires on April 27, 2024. U.S. Patent No. 7,214,696 …
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …7,214,696 expires on December 19, 2023. U.S. Patent No. 9,770,441 expires on August 31, 2035.Thirty Month Stay… 10 August 2023
1:23-cv-00879
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
| 2023-08-10 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,214,695 B2; 7,214,696 B2; 9,770,441… 10 August 2023
1:23-cv-00879
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
